Veterinary Point of Care Diagnostics Market Set to More Than Double by 2032 Amid Rapid Technological Advancements

Global Veterinary Point of Care Diagnostics Market Overview

The global veterinary point of care diagnostics market is witnessing substantial growth, valued at USD 2.59 billion in 2024 and expected to reach USD 5.72 billion by 2032, reflecting a CAGR of 10.41% during 2025–2032. The growth is primarily propelled by technological advancements in portable analyzers, real-time imaging, and cloud-integrated platforms, alongside rising awareness of preventive care among pet owners and livestock managers. Increasing incidences of zoonotic diseases and heightened demand for rapid, accessible diagnostics in both companion and livestock animals are further contributing to the market’s expansion.

Regulatory frameworks in developed regions, particularly the U.S., have bolstered market adoption. FDA approvals of PoC diagnostic devices are ensuring reliability, while R&D investments by key players such as IDEXX Laboratories, Zoetis, and Heska Corporation continue to drive innovation. Microfluidic, immunodiagnostic, and molecular platforms are witnessing significant development, complemented by venture capital funding and robust supply chains enhancing global market reach.

Gain Valuable Market Knowledge: Request a Sample Report: https://www.snsinsider.com/sample-request/7924

Market Dynamics Driving Growth

The primary growth driver for the veterinary point of care diagnostics market is the rising demand for rapid diagnostic turnaround in animal healthcare. Companion animals, in particular, are benefiting from routine and preventive testing as pet owners increasingly prioritize health monitoring. Pet insurance coverage, rising disposable incomes, and consumer spending on veterinary services—over USD 38 billion in the U.S. alone in 2023—have further accelerated diagnostic adoption.

Companies such as Heska and Virbac are expanding PoC testing solutions, while global policies by the World Organisation for Animal Health emphasize early detection and disease control. Mars Petcare’s Waltham Petcare Science Institute exemplifies ongoing R&D in real-time diagnostic technologies, supporting both companion and livestock animal health management.

However, the market faces certain challenges. High initial costs of devices and testing kits limit adoption among smaller clinics, particularly in developing countries. Inconsistent regulatory standards for veterinary diagnostics and limited availability of trained personnel pose additional hurdles. Less than 40% of veterinary practices in low-income regions use PoC diagnostics regularly, reflecting constraints on widespread deployment. Moreover, the FDA approval process can delay the market introduction of advanced PoC devices, creating gaps between innovation and commercial availability.

Product Segmentation Analysis

In 2024, consumables, reagents, and kits held the largest share of the veterinary point of care diagnostics market at 58%. Their affordability, frequent usage, and practicality make them essential for routine diagnostics, including testing for parvovirus, leptospirosis, and other prevalent animal diseases. Meanwhile, instruments and devices are the fastest-growing segment, driven by miniaturized analyzers, portable imaging systems, and integrated devices facilitating rapid clinical decisions. High-volume urban practices particularly benefit from these technological advancements.

Test Type Trends

Immunodiagnostics dominated the market in 2024, accounting for 37% share. These tests provide rapid and accurate detection of infectious diseases, hormone levels, and biomarkers. The growth of molecular diagnostics is notable, as veterinarians increasingly require high-specificity tools for early pathogen detection and genetic disease screening. Portable PCR systems and isothermal amplification techniques are expanding field-based testing capabilities, particularly for high-value livestock and herd health programs.

Animal Type Insights

Companion animals represented 60% of the market in 2024, driven by increased pet ownership, pet humanization, and routine preventive healthcare. Regular diagnostics for conditions such as diabetes, kidney disease, and infections contribute to market growth. Conversely, livestock diagnostics are expected to grow at the fastest CAGR, reflecting rising demand for animal protein, government-led disease surveillance, and early disease detection in agricultural sectors, especially in developing economies with large livestock populations.

Sample and Application Insights

Blood, plasma, and serum samples dominated the market with a 56% share in 2024. These samples facilitate a wide range of diagnostic modalities, including immunodiagnostics, hematology, and molecular testing, crucial for detecting infectious diseases, metabolic disorders, and organ dysfunction. Urine samples represent the fastest-growing segment, increasingly used in renal and urinary tract disease diagnosis, as well as metabolic disorder monitoring.

Infectious diseases held the largest application share at 48% in 2024. Rapid on-site diagnostics for conditions like parvovirus, leptospirosis, feline leukemia, and bovine tuberculosis remain critical due to zoonotic risks and herd management needs. Heredity and congenital disorder diagnostics are emerging as the fastest-growing applications, driven by breeders and pet owners seeking early detection in purebred and high-value animals.

End-Use Segmentation

Veterinary hospitals and clinics dominated the end-use segment in 2024, accounting for 68% of market share. These facilities possess the infrastructure and trained personnel for advanced diagnostic testing. Home care and tele-veterinary services are the fastest-growing segments, driven by portable test kits and hand-held devices enabling early disease detection outside traditional clinic settings.

Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis: https://www.snsinsider.com/reports/veterinary-point-of-care-diagnostics-market-7924

Regional Analysis

North America led the global veterinary point of care diagnostics market in 2024, driven by a well-established veterinary healthcare system, high pet adoption rates, and significant spending on animal care. The U.S. market alone was valued at USD 0.97 billion, expected to reach USD 2.09 billion by 2032. Canada is witnessing growth in mobile diagnostics and preventive pet care awareness.

Europe ranked second, with countries such as Germany and the UK supporting veterinary networks and investments in precision medicine. Livestock management and disease surveillance initiatives across France and Spain are fostering market penetration. The EU’s support for research in molecular diagnostics further accelerates adoption.

Asia Pacific is the fastest-growing region due to rising pet humanization, higher disposable incomes, and expanding livestock populations. China and India are key markets, driven by herd health diagnostics and rural veterinary programs. Japan, South Korea, and ASEAN countries are also contributing to growth through advanced diagnostics and affordable kit deployment.

Key Market Players

Prominent players in the veterinary point of care diagnostics market include IDEXX Laboratories, Zoetis, Heska Corporation, Virbac, Thermo Fisher Scientific, Mindray, FUJIFILM Corporation, Getein Biotech, Eurolyser Diagnostica, Randox Laboratories, AniPOC, Carestream Health, NeuroLogica, bioMérieux, Biotangents, Esaote, GE Healthcare, Skyla Corporation, Scil Animal Care, Abaxis, Bionote, Chison Medical Technologies, IDvet, and QGenda.

Recent innovations include Zoetis’ AI Masses integrated with the Vetscan Imagyst analyzer for rapid cytology and the AI-powered Atrio Pet Pulse wearable ECG monitor trialed in Australia, reflecting a strong trend toward AI-enabled diagnostics and real-time animal health monitoring.

Future Outlook

The veterinary point of care diagnostics market is poised for continued growth, underpinned by technological innovation, rising awareness of preventive animal care, and expansion of tele-veterinary and home-care diagnostics. Portable analyzers, AI integration, and molecular testing platforms will drive further adoption across companion and livestock segments. Market expansion in Asia Pacific, combined with increasing investment in R&D and supportive regulatory frameworks in developed regions, ensures a dynamic growth trajectory through 2032.

Conclusion

The veterinary point of care diagnostics market is undergoing transformative growth, with innovations in AI, molecular diagnostics, and portable devices reshaping animal healthcare. Rising pet ownership, preventive care trends, and increasing demand for rapid, on-site diagnostics are fueling adoption across regions. Despite challenges in cost and regulatory standardization, the market is expected to more than double in value by 2032, highlighting its strategic importance for both companion and livestock animal health management.

Other Trending Reports

Pet Bird Health Market

Dementia Treatment Market

Capillary Blood Collection Devices Market

Cell Separation Market